Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Predictors of disease activity in 857 patients with MS treated with interferon beta-1b.
Corticosteroids provoke acute endothelial injury - an ideal ground for thrombosis in multiple sclerosis.
Does fatigue occur in MS patients without disability? Suggested running head: Fatigue and disability in MS.
Improved patient-reported health impact of multiple sclerosis: The ENABLE study of PR-fampridine.
Amniotic epithelial cells from the human placenta potently suppress a mouse model of multiple sclerosis.
Multiple sclerosis: summary of NICE guidance.
Rebound of disease activity during pregnancy after withdrawal of fingolimod.
Dual role of Response gene to complement-32 in multiple sclerosis.
Accentia Biopharmaceuticals Announces that Revimmune Autoimmune Disease Therapy is Featured in Peer-review Journal
Strategies for myelin regeneration: lessons learned from development.
Lobular panniculitis and lipoatrophy of the thighs with interferon-ß1a for intramuscular injection in a patient with multiple sclerosis.
A pilot randomised controlled trial of an Internet-based cognitive behavioural therapy self-management programme (MS Invigor8) for multiple sclerosis fatigue.
Laquinimod, a Quinoline-3-Carboxamide, Induces Type II Myeloid Cells That Modulate Central Nervous System Autoimmunity.
Coping Strategies in Multiple Sclerosis Patients with Frontal Cognitive Disorders.
Innovation at RUSH
Intramuscular interferon beta-1a is effective in Japanese patients with relapsing-remitting multiple sclerosis: a pre-treatment versus treatment comparison study of gadolinium-enhanced MRI brain lesions.
Forsythiaside A Exhibits Anti-inflammatory Effects in LPS-Stimulated BV2 Microglia Cells Through Activation of Nrf2/HO-1 Signaling Pathway.
The Ambivalent Role of Apoptosis in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis.
Reliability of a cognitive endpoint for use in a multiple sclerosis pharmaceutical trial.
Extracellular O-linked β-N-acetylglucosamine: Its biology and relationship to human disease.
miRNA in multiple sclerosis: search for novel biomarkers.
Subcellular distribution of FTY720 and FTY720-phosphate in immune cells - another aspect of Fingolimod action relevant for therapeutic application.
Epstein-Barr virus latent membrane protein 2A exacerbates experimental autoimmune encephalomyelitis and enhances antigen presentation function.
Riluzole (2-amino-6-trifluoromethoxy benzothiazole) attenuates MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) neurotoxicity in mice.
Accuracy of StepWatch™ and ActiGraph Accelerometers for Measuring Steps Taken among Persons with Multiple Sclerosis.

Pages